Large Study Finds Statin-Related Serious Muscle Problems Affect Less Than 1% of Users
By
David Mills
Summary
A large study published in The Lancet Digital Health found that the risk of serious muscle problems for people taking statins is extremely low — less than 1% of participants had a 10-year risk of statin-related serious muscular disorders higher than 10%. The findings aim to counter widespread fears about muscle-related side effects that lead many people to avoid or stop taking the cholesterol-lowering medication, despite experts emphasizing that the cardiovascular benefits of statins far outweigh the risks.
Source
Twitter / XLarge Study Finds Statin-Related Serious Muscle Problems Affect Less Than 1% of Usershealthline.comKey quotes
· 3 pulledResearchers said less than 1% of people who took the commonly prescribed cholesterol-lowering medication in a study had a 10-year risk of statin-related serious muscular disorders higher than 10%.
Many people avoid statins out of fear of side effects like muscle aches, but experts say the benefits of the commonly prescribed medication outweigh the risks.
The results of the study were published on June 25 in The Lancet Digital Health.
You might also wanna read
New calculator reveals whether you should really worry about statin side effects
Statins and blood pressure drugs changing health risks of obesity, study suggests
UK pharmacy owner warns of severe drug shortages affecting statins, heart medication, and other essential medicines
Pharmacy owner Mo Almobaraki warns that the UK is experiencing its most severe drug shortage on record, affecting millions who take statins,
mirror.co.uk·17d ago
The hidden risks of daily supplement use: What social media ads don't tell you
A personal reflection on the prevalence of supplement use, revealing how even skeptical individuals can accumulate various supplements (crea
bbc.co.uk·16d ago
Statins helping people with obesity match those of healthy weight on key metrics, study finds
Clinical Trials Exclude High-Risk Patients, Underestimating Drug Harms
This research paper examines how clinical trials systematically exclude high-risk patients, leading to underestimation of drug harms and sid
nber.org·7mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.